Facts on Drugs Used in Chemotherapy
Active substance: Mitomycin
Manufacturer: Bristol-Myers Squibb
Extract from the prescribing information:
"This was the most common and most serious toxicity, occurring in 605 of 937 patients (64.4%). Thrombocytopenia and/or leukopenia may occur anytime within 8 weeks after onset of therapy with an average time of 4 weeks."
"Patients should be advised of the potential toxicity of this drug, particularly bone marrow suppression. Deaths have been reported due to septicemia as a result of leukopenia due to the drug."
The above has been extracted from the Mutamycin prescribing information on the Bristol-Myers Squibb webpages.